Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular.

Slides:



Advertisements
Similar presentations
Get to Goal, Achieve Control
Advertisements

Treatment of hypertension: What are the new standards of care?
1 Mark Huffman, MD, MPH Northwestern University Feinberg School of Medicine Northwestern Memorial Hospital Healthy Transitions 21 November 2013 Blood Pressure.
ECG Lectures ECG Lectures Part 2 Hypertrophies and Enlargements Selim Krim, MD Assistant Professor Texas Tech University Health Sciences Center.
Dementia IGHC Tatiana Kuznetsova, Jan A. Staessen University of Leuven, Belgium Diagnostic criteria for subclinical systolic and diastolic LV function.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Atrial and Ventricular Enlargement
Comparison between Central and Peripheral Pulse Pressure as Determinants of Intermediate Cardiovascular Phenotypes C Delles, U Neisius, G Bilo, C Taurino,
Cholesterol quintile (mg/dL)
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Left Ventricular Hypertrophy Detection, significance and treatment.
Update on Genetics in Hypertension Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular and Medical Sciences University.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Blood pressure parameters and pulse wave velocity for cardiovascular-renal prevention Jacques Blacher Unité HTA, prévention et thérapeutique cardiovasculaires.
The concept of Diabetes & CV risk: A lifetime risk challenge
Specific guidelines on the use of arterial measurements Jiguang WANG, MD, PhD Professor of Cardiovascular Medicine The Shanghai Institute of Hypertension,
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Interpreting blood tests and the ECG: practical risk assessment
Jennifer Doria-del Castillo
Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.
Casablanca, le 30 Avril 2011 MEDITERANEAN GROUP FOR STUDY DIABETES.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Blood pressure control in primary health care WORKSHOP
1 Current & New treatment strategies to address CV Risk.
Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph.
1 بسم الله الرحمن الرحیم. Atrial and Ventricular Hypertrophy ECG Features and Common Causes ALI BARABADI University of Guilan.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Monocyte damaged endothelium macrophage foam cell lipid thrombocytes plaque oxidative stress smooth muscle cells 4 5 Gaviraghi et al., 1998 Lacidipine:
PWV & PWA Parameter Extraction / Transfer Function.
The Heart in Hypertension Jamil Mayet. Left Ventricular Hypertrophy - a historical perspective Association between renal disease and LVH –Richard Bright.
ASCOT and Steno-2: Aggressive risk reduction benefits two different patient populations *Composite of CV death, nonfatal MI or stroke, revascularization,
Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:
7 April 2013 WORLD HEALTH DAY. World Health Day 2 On 7 April 1948, the World Health Organization (WHO) was created. Since then, WHO named April 7 as World.
2015 Canadian Hypertension Education Program Recommendations
Slide Source: Lipids Online Slide Library Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Design Sever PS et al. J Hypertens 2001;19:1139–1147.
To establish whether a difference in SBP between arms is associated with peripheral or cardiovascular (CV) disease, and with an increased risk of CV or.
2007 Hypertension as a Public Health Risk January, 2007.
Don’t Worry I am Ok! Goal of project GOAL OF PROJECT  TO AWARE ABOUT HEART DISEASES.  TO UNDERSTAND CAUSES OF HEART DISEASES.  TO AWARE PREVENTIVE.
ECG in myocardial ischemia and other pathologic processes Prof. Hanáček
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.
高血压. 内容 高血压定义及心脏损害 高血压定义及心脏损害高血压治疗及指南概况  高血压的治疗的目标  高血压的药物选择.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Use of Relaxation Time as a Marker for Arterial Distensibility C.C. Winchester, N.-Y. Chou, and L.W. Winchester University of Mary Washington, Fredericksburg,
Over Time Additional Risk Factors Can Progress: Effect of Cholesterol and BP on CHD Risk in MRFIT Trial
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Antonio Coca, MD, PhD, FRCP, FESC
1 Figure 1: Patient Setup and Sample VENDYS DTM Report
DATA INTERPRETATION-1 1. BASIC ECG 2. Lipid Profile
Effect of cigarette smoking on myocardial workload in young adults
PULSE WAVE VELOCITY IN VESSELS
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Mario F. Rubin, MD, Sylvia E. Rosas, MD, Julio A
LVH Criteria Sokolow + Lyon
Volume 68, Issue 2, Pages (August 2005)
Correlation between endothelial function and hypertension
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Prevalence of the clinical, ECG and echocardiographic signs in the group with moderate and severe IVST increase in the THAOS population with echocardiography.
Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.
Presentation transcript:

Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular and Medical Sciences University of Glasgow

Joint British Societies Cardiovascular Risk

2013 ESH/ESC Guidelines. J Hypertens 2013 Organ Damage and Cardiovascular Risk

Dzau V et al. Circulation 2006 The Cardiovascular Continuum

ESH Taskforce Document. J Hypertens 2009 Subclinical Organ Damage and CV Risk Study Tsioufis Mihani CASE-J trial CV Health Study ELSA Laurent Fowkes De Buyzere Koren Tsioufis HOT INSIGHT Jensen Condition Hypertension Outpatients Hypertension Elderly Hypertension Outpatients Hypertension 10 yr CVD ≥ 20% Yes Yes (men) Yes Yes (CHD) Organ damage LVH (echo)  Ca IMT (highest quintile)  Ca IMT (2 highest quintiles) PWV (highest quintile)  Ankle / brachial ratio LVH (echo) Low eGFR Low eGFR or high SCR (≥ 1.5 mg/dl) MA

Heart

Schmieder RE. Dtsch Arztebl Int 2010 ECG: Indices of Left Ventricular Hypertrophy Sokolow-Lyon Index: S V1 + R V5/6 ≥ 3.8 mV (3.5 mV) Cornell Voltage Product: Men: (R aVL + S V3 ) × QRS > 244 mV msec Women: (R aVL + S V3 +0.8) × QRS > 244 mV msec

e-cardiogram.com ECG: Sokolow-Lyon Index

ECG Voltage Criteria and CV Events Levy D at al. Circulation 1994

Echocardiography

2013 ESH/ESC Guidelines. J Hypertens 2013

Left Ventricular Mass and CV Events Schillaci G et al. Hypertension 2000

The ECG is valuable [for detection of LVH], at least in patients over 55 years of age. Electrocardiography can also be used to detect patterns of ventricular overload or ‘strain’, which indicates more severe risk, ischaemia, conduction abnormalities, left atrial dilatation and arrhythmias, including atrial fibrillation ESH/ESC Guidelines. J Hypertens 2013 Cardiac Damage

Echocardiography should be considered in hypertensive patients in different clinical contexts and with different purposes: in hypertensive patients at moderate total CV risk, it may refine the risk evaluation by detecting LVH undetected by ECG in hypertensive patients with ECG evidence of LVH it may more precisely assess the hypertrophy quantitatively and define its geometry and risk in hypertensive patients with cardiac symptoms, it may help to diagnose underlying disease ESH/ESC Guidelines. J Hypertens 2013 Cardiac Damage

Blood Vessels

Dzau V et al. Circulation 2006 The Cardiovascular Continuum

Endothelial Function: Flow-mediated Dilatation

Vascular Stiffness and CV Events Willum-Hansen T et al. Circulation 2006

Blood Pressure Determines CV Risk Prospective Studies Collaboration. Lancet 2002

Pulse Pressure Refines CV Risk Franklin SS et al. Circulation 1999

Atherosclerosis and Vascular Stiffness Ng et al. Am J Physiol Renal Physiol 2011 Wikipedia.org

Vascular Stiffness: Pulse Wave Velocity

Vascular Stiffness and Mortality Relative Risk of Cardiovascular Mortality According to PWV and Cardiovascular Risk Factors: Univariate Analysis ParametersORLower 95% CIHigher 95% CIP PWV, 5 m/s < Previous CVD, yes/no < Age, 10 y < PP, 10 mm Hg < SBP, 10 mm Hg <0.001 Diabetes, yes/no <0.001 Laurent S et al. Hypertension 2001

Carotid Intima-Media Thickness Barth JD. Am J Cardiol 2002 Healthy subject Patient with arterial hypertension and hypercholesterolaemia